These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 30190126)

  • 1. SPOP promotes FADD degradation and inhibits NF-κB activity in non-small cell lung cancer.
    Luo J; Chen B; Gao CX; Xie HK; Han CN; Zhou CC
    Biochem Biophys Res Commun; 2018 Sep; 504(1):289-294. PubMed ID: 30190126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPOP promotes SIRT2 degradation and suppresses non-small cell lung cancer cell growth.
    Luo J; Bao YC; Ji XX; Chen B; Deng QF; Zhou SW
    Biochem Biophys Res Commun; 2017 Feb; 483(2):880-884. PubMed ID: 28073696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPOP inhibits mice pancreatic stellate cell activation by promoting FADD degradation in cerulein-induced chronic pancreatitis.
    Tan P; Wang A; Chen H; Du Y; Qian B; Shi H; Zhang Y; Xia X; Fu W
    Exp Cell Res; 2019 Nov; 384(1):111606. PubMed ID: 31493386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HS3ST1 Promotes Non-Small-Cell Lung Cancer Progression by Targeting the SPOP/FADD/NF-
    Ji X; Cheng K; Gao C; Xie H; Zhu R; Luo J
    Biomed Res Int; 2022; 2022():5509346. PubMed ID: 35909476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas.
    Chen G; Bhojani MS; Heaford AC; Chang DC; Laxman B; Thomas DG; Griffin LB; Yu J; Coppola JM; Giordano TJ; Lin L; Adams D; Orringer MB; Ross BD; Beer DG; Rehemtulla A
    Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12507-12. PubMed ID: 16109772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and mutation of Fas-associated death domain (FADD) gene in non-small cell lung cancer].
    Yang Q; Zhu RQ; Fang Z; Xia D; Diao LM; Liu MQ
    Ai Zheng; 2005 Mar; 24(3):321-6. PubMed ID: 15757534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BTB domain-containing speckle-type POZ protein (SPOP) serves as an adaptor of Daxx for ubiquitination by Cul3-based ubiquitin ligase.
    Kwon JE; La M; Oh KH; Oh YM; Kim GR; Seol JH; Baek SH; Chiba T; Tanaka K; Bang OS; Joe CO; Chung CH
    J Biol Chem; 2006 May; 281(18):12664-72. PubMed ID: 16524876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
    Op den Kamp CM; Langen RC; Minnaard R; Kelders MC; Snepvangers FJ; Hesselink MK; Dingemans AC; Schols AM
    Lung Cancer; 2012 Apr; 76(1):112-7. PubMed ID: 22018880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPOP suppresses osteosarcoma invasion via PI3K/AKT/NF-κB signaling pathway.
    Chen L; Pei H; Lu SJ; Liu ZJ; Yan L; Zhao XM; Hu B; Lu HG
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):609-615. PubMed ID: 29461588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear localized phosphorylated FADD induces cell proliferation and is associated with aggressive lung cancer.
    Bhojani MS; Chen G; Ross BD; Beer DG; Rehemtulla A
    Cell Cycle; 2005 Nov; 4(11):1478-81. PubMed ID: 16258269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
    Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C
    Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-κB pathway.
    Chen J; Gu J; Feng J; Liu Y; Xue Q; Ni T; Wang Z; Jia L; Mao G; Ji L
    Tumour Biol; 2016 Mar; 37(3):3851-61. PubMed ID: 26476534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRL3-SPOP ubiquitin ligase complex suppresses the growth of diffuse large B-cell lymphoma by negatively regulating the MyD88/NF-κB signaling.
    Jin X; Shi Q; Li Q; Zhou L; Wang J; Jiang L; Zhao X; Feng K; Lin T; Lin Z; Zhuang H; Yang J; Hu C; Zhang L; Shen L; Lu Y; Zhu J; Wang H; Qi H; Meng X; Xi Y; Pan J; Fang S; Tian H; Zhou C; Zhang P; Gao K; Zhao SM; Li Y; Gong Z; Wang C
    Leukemia; 2020 May; 34(5):1305-1314. PubMed ID: 31776466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FADD protein release mirrors the development and aggressiveness of human non-small cell lung cancer.
    Cimino Y; Costes A; Damotte D; Validire P; Mistou S; Cagnard N; Alifano M; Régnard JF; Chiocchia G; Sautès-Fridman C; Tourneur L
    Br J Cancer; 2012 Jun; 106(12):1989-96. PubMed ID: 22669160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E2 upregulates β1 integrin expression via the E prostanoid 1 receptor/nuclear factor κ-light-chain-enhancer of activated B cells pathway in non-small-cell lung cancer cells.
    Bai X; Yang Q; Shu W; Wang J; Zhang L; Ma J; Xia S; Zhang M; Cheng S; Wang Y; Leng J
    Mol Med Rep; 2014 May; 9(5):1729-36. PubMed ID: 24584670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPOP promotes ubiquitination and degradation of MyD88 to suppress the innate immune response.
    Li Q; Wang F; Wang Q; Zhang N; Zheng J; Zheng M; Liu R; Cui H; Wen J; Zhao G
    PLoS Pathog; 2020 May; 16(5):e1008188. PubMed ID: 32365080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Speckle-type POZ protein suppresses hepatocellular carcinoma cell migration and invasion via ubiquitin-dependent proteolysis of SUMO1/sentrin specific peptidase 7.
    Ji P; Liang S; Li P; Xie C; Li J; Zhang K; Zheng X; Feng M; Li Q; Jiao H; Chi X; Zhao W; Zhang S; Wang X
    Biochem Biophys Res Commun; 2018 Jul; 502(1):30-42. PubMed ID: 29777712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple functions of FADD in apoptosis, NF-κB-related signaling, and heart development in Xenopus embryos.
    Sakamaki K; Takagi C; Kitayama A; Kurata T; Yamamoto TS; Chiba K; Kominami K; Jung SK; Okawa K; Nozaki M; Kubota HY; Ueno N
    Genes Cells; 2012 Nov; 17(11):875-96. PubMed ID: 23025414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.
    Zhang Z; Ma J; Li N; Sun N; Wang C
    Ann Thorac Surg; 2006 Jul; 82(1):243-8. PubMed ID: 16798222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piperlongumine inhibits lung tumor growth via inhibition of nuclear factor kappa B signaling pathway.
    Zheng J; Son DJ; Gu SM; Woo JR; Ham YW; Lee HP; Kim WJ; Jung JK; Hong JT
    Sci Rep; 2016 May; 6():26357. PubMed ID: 27198178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.